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INTRODUCTION 
The arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited heart disease. It is 
characterized by death of myocytes in the right ventricle and their replacement by fibro-fatty tissue. Major 
genetic defects are found in desmosomes whose function is cell adhesion. Sudden cardiac death (SCD) is the 
main problem of ARVD; around of 20% of SCD are involved by ARVD (table 1). 50% of cases have familial 
distribution with at least one affected patient. The pattern of inheritance is AD and the prevalence range is 
:2500, but varies between populations.   
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SYMPTOMS: (figure 1) 
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OBJECTIVES 
The main objective is to discuss the possibility of applying genomics to biomedicine as a genetic test for a long-term disease, for example in ARVD; extrapolating 
this use in many diseases such as cancer and cardiomyopathies. In particular, presentation of all features of ARVD: clinical characteristics, genetic causes, genetic 
testing and genetic counseling. Also, introducing a real case to explain improvement of applying genomic testing.    
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REAL CASE 
To introduce genetic testing in ARVD, here it 
is presented a familiar with two affected 
females (figure 2). They were diagnosed 
when they were 30-35 years old. 
Any genetic test hasn't been done and any 
mutation hasn't been found. Also, sons and 
daughters are too young to present any 
clinical symptoms. The possible genetic 
 is explained in this work.   
 
GENETIC CAUSES 
 
 
 
 
 
 
 
 
 
 
 
PKP2: is the most prevalent gene affected in ARVD. There are more 
than 150 pathogenic mutations identified only in PKP2 that represent 
35-40% of total ARVD cases. A lot of types of mutations have been 
detected (CNV, splicing, missense, nonsense and frameshift). 
    
DSC2, DSG2, DSP and JUP are genes that encodes desmosomes, too 
(table 2 and figure 3). More than 200 mutations have been found in 
this four genes. Majority of variations are punctual changes as 
missense mutations. All types of mutations may be detect.  
 
Non-desmosomal genes: recent genes have been discovered, these 
could relate with cases of misdiagnosis and are important in genetic 
test; their prevalence is low (10%). These genes are: DES, TGFβ3, 
TMEM43, LMNA, TTN and PLN (table 2). They encode, mainly, 
intermediate filaments or regulatory elements.  
 
In ARVD/C Genetic Variants Database, it is possible to find all variants 
in this 12 genes with all important information.  For  that is a good tool 
for genetic diagnostic. 
 
GENETIC TESTING 
The major diagnosed people has a mutation in PKP2 (40%), around 40% 
people is not diagnosed and other 20% is affected different other genes. 
 
oThere are techniques used to find variations only in one sequence of the 
genome: Sanger sequencing (A) and MLPA (B). Usually, are the first steps 
to look for a mutation in PKP2. 
 
 
 
 
 
oMore genetic causes in different chromosomes, it would be more 
efficient to use a whole-genome technique (C). Next Generation 
Sequencing (NGS) is the most useful test to find variations (D).  
 
 
 
 
 
 
oIdentifying variations in ARVD/C Genetic Variants Database (E) to know 
all information of this variant.  
 
 
ETHICAL QUESTIONS 
   
Key information and suggestions that cardiologists should know: 
Genetic testing in patients and relatives (al least two diagnosed in a family) 
•Interpretation of the results: mode of inheritance and risk recurrence, 
molecular genetics, penetrance and natural history and variable expressivity. 
•Organization of genetic counselling, principles of bioethics.  
Possible prenatal or preimplantation diagnostic if variations have been found.  
families and the manner to help to improve their life.  
CONCLUSIONS 
ARVD is a polygenic disease and can evolve to a SCD (20%) or other malignant symptoms.  
Applying genomics to biomedicine may help as a good tool in some complicated diseases as 
cardiomyopathies or cancer. 
Whole-genome testing will be important in research and diagnostic to these diseases.  
Genetic causes and diagnostic of ARVD have been explained to solve real cases of affected 
TABLE 2: GENES ASSOCIATED WITH ARVD. 
GENE LOCUS PROTEIN 
CTNNA3 10q21.3 αT-catenin 
DES 2q35 Desmin 
DSC2 18q21 Desmocollin-2 
DSG2 18q12.1 Desmoglein-2 
DSP 6p24 Desmoplakin 
JUP 17q21 Junction plakoglobin 
LMNA 1q22 Lamin A/C 
PKP2 12p11 Plakophilin-2 
PLN 6q22.1 Phospholamban 
TGFβ3 14q24.3 Transforming growth factor β 3 
TMEM43 3p25.1 Transmembrane protein 43 
TTN 2q31.2 Titin 
TABLE 1: CAUSES OF SUDDEN CARDIAC DEATH (%) IN PEOPLE 
UNDER 35 YEARS OLD. Corrado et al. (1998) 
CAUSES ATHLETES  NO  ATHLETES   TOTAL  
Arrhythmogenic right ventricular dysplasia 22,4 8,2 10,8 
Coronary arteriosclerosis 18,4 16,4 16,7 
Anomalous coronary arteries 12,2 0,5 2,6 
Conduction system disease 8,2 9,1 8,9 
Mitral valve prolapse  10,2 9,5 9,7 
Figure 1: Symptoms of ARVD and its frequencies. 
Figure 2: Pedigree of real case.  
□=males ○= females ●= illness 
Figure 3: Molecular model of desmosomes. 
Genes are PKP2, DSC2, DSG2, DSP and JUP. 
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